Amsterdam, Netherlands

Ada M Kruisbeek

This inventor holds 1 USPTO granted patent. Top assignees: Crucell Holland B.v., Johns Hopkins University. Active years: 2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ada M Kruisbeek. Retrieved from https://idiyas.com/inventor/ada-m-kruisbeek

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 28(Granted Patents)


Company Filing History:


Years Active: 2011

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Ada M Kruisbeek

Introduction

Ada M Kruisbeek is a notable inventor based in Amsterdam, Netherlands. She has made significant contributions to the field of biotechnology, particularly in the development of human binding molecules. Her work has implications for the diagnosis, prevention, and treatment of neoplastic disorders and diseases.

Latest Patents

Kruisbeek holds a patent for a human binding molecule against CD1a. This invention provides human binding molecules that specifically bind to CD1, along with nucleic acid molecules encoding these binding molecules. The compositions comprising the human binding molecules can be utilized in various medical applications, enhancing the potential for innovative treatments.

Career Highlights

Throughout her career, Ada M Kruisbeek has worked with prestigious institutions, including Johns Hopkins University and Crucell Holland B.V. Her experience in these organizations has allowed her to collaborate with leading experts in the field, further advancing her research and innovations.

Collaborations

Some of her notable coworkers include Mark Throsby and Marja Van Meijer. Their collaborative efforts have contributed to the success of her projects and the advancement of their shared goals in biotechnology.

Conclusion

Ada M Kruisbeek's work exemplifies the impact of innovative research in biotechnology. Her contributions continue to pave the way for advancements in medical science and treatment options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…